Volitionrx Ltd financial data

Symbol
VNRX on NYSE
Industry
In Vitro & In Vivo Diagnostic Substances
Location
1489 West Warm Springs Road, Suite 110, Henderson, Nevada
State of incorporation
Delaware
Fiscal year end
December 31
Former names
STANDARD CAPITAL CORP (to 9/29/2011)
Latest financial report
Q1 2024 - May 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 69.2 % -21.1%
Debt-to-equity -592 % -114%
Return On Equity 612 %
Return On Assets -152 % -0.39%
Operating Margin -4.43 K % +54.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 82.1 M shares +30.1%
Common Stock, Shares, Outstanding 82.1 M shares +30.1%
Entity Public Float 82.2 M USD +12%
Common Stock, Value, Issued 82.1 K USD +30.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 797 K USD +133%
Research and Development Expense 19.3 M USD +15.8%
Selling and Marketing Expense 6.81 M USD +1.85%
General and Administrative Expense 10 M USD -1.15%
Costs and Expenses 803 K USD
Operating Income (Loss) -35.3 M USD -6.57%
Nonoperating Income (Expense) 51 K USD -96.3%
Net Income (Loss) Attributable to Parent -35.3 M USD -11.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 11.8 M USD +17.6%
Accounts Receivable, after Allowance for Credit Loss, Current 134 K USD +12.6%
Other Assets, Current 470 K USD -34.4%
Assets, Current 13.5 M USD +12.6%
Property, Plant and Equipment, Net 5.18 M USD -4.1%
Operating Lease, Right-of-Use Asset 569 K USD -4.04%
Intangible Assets, Net (Excluding Goodwill) 215 K USD +137%
Assets 19.4 M USD +7.71%
Accounts Payable, Current 3.53 M USD +18%
Accrued Liabilities, Current 3.31 M USD +21.6%
Liabilities, Current 31.5 M USD +82.7%
Operating Lease, Liability, Noncurrent 396 K USD +3.84%
Liabilities 36.1 M USD +71.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 259 K USD +51.8%
Retained Earnings (Accumulated Deficit) -211 M USD -19.8%
Stockholders' Equity Attributable to Parent -15.6 M USD -568%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -16.6 M USD -458%
Liabilities and Equity 19.4 M USD +7.71%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.34 M USD +4.6%
Net Cash Provided by (Used in) Financing Activities -209 K USD -103%
Net Cash Provided by (Used in) Investing Activities -78.8 K USD +60.7%
Common Stock, Shares Authorized 100 M shares 0%
Common Stock, Shares, Issued 82.1 M shares +30.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.96 M USD -946%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11.8 M USD +17.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 77.2 K USD +50.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 709 K USD
Depreciation 278 K USD +10.6%
Payments to Acquire Property, Plant, and Equipment 28.8 K USD -85.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -35.2 M USD -11.3%
Property, Plant and Equipment, Gross 9.57 M USD +6.25%
Operating Lease, Liability, Current 201 K USD -15.8%
Additional Paid in Capital 195 M USD +12.4%
Amortization of Intangible Assets 14.3 K USD -32.3%
Share-based Payment Arrangement, Expense 335 K USD -32.2%
Interest Expense 155 K USD +11.9%